Idea principal
In 88 adults with obesity and nonalcoholic fatty liver disease (NAFLD), time-restricted eating (TRE) cut liver fat about as much as ordinary calorie restriction, with a difference of 1.0 percentage point at 12 months (95% CI -1.6 to 3.5; P = .45). Both groups ate a similar calorie-restricted diet, and the trial was single-centre and fairly small, so it cannot rule out small differences.
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Time-restricted eating, which limits food to a fixed daily window, is popular, but its effect and safety in fatty liver disease were uncertain. The authors compared TRE with daily calorie restriction (DCR) for liver fat and metabolic risk factors in people with obesity and NAFLD.
Población y método
Randomized clinical trial lasting 12 months at Nanfang Hospital in Guangzhou, China, between April 9, 2019, and August 28, 2021. Adults with obesity and NAFLD were assigned to TRE (eating only between 8:00 am and 4:00 pm) or DCR (habitual meal timing). Everyone was told to eat 1500 to 1800 kcal/d (men) or 1200 to 1500 kcal/d (women). The primary outcome was change in intrahepatic triglyceride (IHTG) content measured by magnetic resonance imaging. Secondary outcomes included weight, waist, body fat and metabolic risk factors, with intention-to-treat analysis.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Liver fat fell in both groups at 6 months: by 8.3% (95% CI -10.0% to -6.6%) with TRE and 8.1% (95% CI -9.8% to -6.4%) with DCR. The difference between groups was -0.2 percentage points (95% CI -2.7 to 2.2; P = .86).
- 2At 12 months liver fat was down 6.9% (95% CI -8.8% to -5.1%) with TRE and 7.9% (95% CI -9.7% to -6.2%) with DCR, a difference of 1.0 percentage point (95% CI -1.6 to 3.5; P = .45). The groups were therefore comparable.
- 3Liver stiffness, body weight and metabolic risk factors were significantly and comparably reduced in both groups.
- 4The 88 participants (mean age 32.0 years, 49 men) were randomised to TRE (n = 45) or DCR (n = 43).
Límites e incertidumbre
- 1Both arms followed the same prescribed calorie limits, so the trial tests meal timing on top of calorie restriction, not TRE against eating freely.
- 2Only 88 people from one hospital in China took part, with a mean age of 32.0 years, so results may not apply to older adults or other settings.
- 3The confidence intervals allow differences of a few percentage points either way, and the abstract does not report how many dropped out.
- 4This reading is based on the abstract only.
Relevancia práctica
For people with fatty liver and obesity, the benefit seen here appeared to come from eating fewer calories, and restricting meals to an eight-hour window added nothing measurable. Choose the approach you can actually keep up. Treatment of fatty liver should be decided with your clinician.
Tus datos
Weight, waist circumference and a food log of daily calories are the useful personal numbers here. A feeding-window tracker can show your eating window, but this trial suggests the calorie total mattered more. Weigh yourself under the same conditions and look at multi-week trends.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Importance
The efficacy and safety of time-restricted eating (TRE) on nonalcoholic fatty liver disease (NAFLD) remain uncertain.
Objective
To compare the effects of TRE vs daily calorie restriction (DCR) on intrahepatic triglyceride (IHTG) content and metabolic risk factors among patients with obesity and NAFLD.
Design, setting, and participants
This 12-month randomized clinical trial including participants with obesity and NAFLD was conducted at the Nanfang Hospital in Guangzhou, China, between April 9, 2019, and August 28, 2021.
Interventions
Participants with obesity and NAFLD were randomly assigned to TRE (eating only between 8:00 am and 4:00 pm) or DCR (habitual meal timing). All participants were instructed to maintain a diet of 1500 to 1800 kcal/d for men and 1200 to 1500 kcal/d for women for 12 months.
Main outcomes and measures
The primary outcome was change in IHTG content measured by magnetic resonance imaging; secondary outcomes were changes in body weight, waist circumference, body fat, and metabolic risk factors. Intention-to-treat analysis was used.
Results
A total of 88 eligible patients with obesity and NAFLD (mean [SD] age, 32.0 [9.5] years; 49 men [56%]; and mean [SD] body mass index, 32.2 [3.3]) were randomly assigned to the TRE (n = 45) or DCR (n = 43) group. The IHTG content was reduced by 8.3% (95% CI, -10.0% to -6.6%) in the TRE group and 8.1% (95% CI, -9.8% to -6.4%) in the DCR group at the 6-month assessment. The IHTG content was reduced by 6.9% (95% CI, -8.8% to -5.1%) in the TRE group and 7.9% (95% CI, -9.7% to -6.2%) in the DCR group at the 12-month assessment. Changes in IHTG content were comparable between the 2 groups at 6 months (percentage point difference: -0.2; 95% CI, -2.7 to 2.2; P = .86) and 12 months (percentage point difference: 1.0; 95% CI, -1.6 to 3.5; P = .45). In addition, liver stiffness, body weight, and metabolic risk factors were significantly and comparably reduced in both groups.
Conclusions and relevance
Among adults with obesity and NAFLD, TRE did not produce additional benefits for reducing IHTG content, body fat, and metabolic risk factors compared with DCR. These findings support the importance of caloric intake restriction when adhering to a regimen of TRE for the management of NAFLD.
Trial registration
ClinicalTrials.gov Identifiers: NCT03786523 and NCT04988230.
Fuentes y atribución
Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial.
Wei X, Lin B, Huang Y, Yang S, Huang C, Shi L, Liu D, Zhang P, Lin J, Xu B, Guo D, Li C, He H, Liu S, Xue Y, Xu Y, Zhang H.
JAMA network open · 2023-03-01
DOI: 10.1001/jamanetworkopen.2023.3513 ↗PubMed · 36930148 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

